During Monday’s Afternoon trade, Shares of XBiotech Inc (NASDAQ:XBIT), higher 80.13% to $15.51.
XBiotech (XBIT), declared that it met the primary endpoint in its European Phase III clinical study of Xilonix(TM), a novel therapy for patients with symptomatic, advanced colorectal cancer. Patients enrolled in the double-blinded, placebo-controlled study had refractory, metastatic colorectal cancer and suffered from cancer-associated symptoms such as fatigue, pain, elevated inflammatory markers, weight loss and reduced physical ability at baseline. Patients were randomized 2:1 to receive either Xilonix therapeutic antibody or placebo, respectively.
John Simard, CEO of XBiotech, stated, "We are gratified to declare these findings with Xilonix. The ability of Xilonix to assist improve the health of patients with cancer has been demonstrated. We look forward to seeking approval to deliver this unprecedented cancer agent to patients."
XBiotech, Inc. (XBIT) is presently at $13.00 and volatility of 9.36% with a market cap of 277, a volume of 1,158,710 shares and a weekly performance of 8.99%.
XBiotech, Inc. (XBIT)’S monthly performance stands at -39.54% and XBiotech, Inc. (XBIT) is considered a stock to watch with an analyst rating of 2.00 (Scale = 5 Strong Sell – 3 Neutral – 1 Strong Buy)
Shares of Keurig Green Mountain Inc (NASDAQ:GMCR), inclined 73.20% to $89.55, during its current trading session.
Keurig Green Mountain (NASDAQ:GMCR) declared Monday that it's going private in a $13.9 billion deal that will combine it with other major coffee brands, following a steep dive in its stock, according to Investor's Business Daily
The maker of brewers and single-serve K-cup pods is being attained by JAB Holding for $92 per share in cash. JAB is a majority owner in Peet's Coffee & Tea and Caribou Coffee and owns the parent company of Einstein Noah Restaurant Group.
"Keurig Green Mountain represents a major step forward in the creation of our global coffee platform," said JAB Chairman Bart Becht in a release. "It is a fantastic company that uniquely brings together premium coffee brands and new beverage dispensing technologies like the famous Keurig single serve machine."
On the other news report, Keurig Green Mountain (GMCR) finally found a way to stop halt its tumbling share price–it’s going private, and that’s great news for Coca-Cola (KO), according to Barrons
This morning, Keurig declared that it would be taken over for $92 by a group led by JAB Holding Co., and also comprises Mondelez International (MDLZ) and BDT Capital Partners. It’s not just the price, which is 78% above Friday’s close, that makes sense for Keurig, says Wells Fargo’s Bonnie Herzog. She notes that JAB has stakes in other coffee companies, counting Jacobs Douwe Egberts, Peet’s Coffee & Tea, and Caribou Coffee, and she argues that it will also be good for Keurig KOLD, the company’s cold beverage system that looks like a bust so far, which JAB will be able to support in a way that Keurig wouldn’t be able to do as a public company.
Finally, Shares of Acorn International, Inc. (ADR) (NYSE:ATV), gained 12.74%, and is now trading at $9.56.
On November 19, Acorn International, Inc. (ATV) ("Acorn" or the "Company"), a marketing and branding company in China engaged in developing, promoting and selling products through extensive direct and distribution networks, recently declared that it will change the ratio of its American depositary shares ("ADSs") to ordinary shares, par value $0.01 per share ("Shares") from 1:3 to 1:20 (the "Ratio Change"). The effective date of the Ratio Change is predictable to be on November 30, 2015.
Following the Ratio Change, the record holders of the Company's ADS as of the effective date will be entitled to receive three (3) new ADS, each representing twenty (20) Shares, in exchange for every twenty (20) ADSs surrendered by them (or, stated another way, 0.15 new ADSs for each ADSs surrendered by them).
The Company believes that the Ratio Change is in the best interests of its shareholders as it will assist the Company in regaining compliance with the minimum average closing price continued listing standard of the NYSE. However, the Company can give no assurance that this aim will be achieved upon the effectiveness of the Ratio Change.
DISCLAIMER:
This article is published by www.stocksnewswire.com. The content included in this article is just for informational purposes only. Stocksnewswire.com takes sensible consideration to ensure that the data given in this article is up to date and accurate. The news, prices, opinions, research, analysis, and other information published in this article are obtained from sources believed to be reliable.
Neither Stocksnewswire.com nor any of Stocksnewswire.com partners make any representation or guarantee as to the fulfillment or precision of the information contained in this article.
Investors must consult their own additional due diligence with any potential investment or highlighted company before making any decision on behalf of information offered by Stocksnewswire.com.
Information contained in this article may contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long-term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.